Regenerative Medicine: From Biomaterials to Applications

Dear Colleagues,

Recent advancement in regenerative medicine deserves strong attention due to the potential in revolutionising the conventional medical approaches. While self-immunity has been recognised as the key factor to recover various health functions at cellular levels, critically damaged or structurally altered cells have been long considered ‘incurable’ and in such cases, whereby removal or artificial interventions were the only viable options. Technology in regenerative medicine can, however, allow manipulation of gene expressions and conditioning of cellular environments via various methods. A couple of recent examples include the discovery of induced pluripotent stem (iPS) cells and the application of messenger ribonucleic acid (RNA), famous for COVID-19 vaccination. These new trends are the real hope for many severe health conditions, including spinal cord injury, cancer, cartilage regeneration, and, ultimately, ‘ageing’ itself. It is, therefore, crucial to collect and share the latest information about regeneration medicine to advance this promised field of research forward. The current collection, “Regenerative Medicine from Biomaterials to Applications”, welcomes all types of submissions that help to pioneer the research area, including original experimental research manuscripts, comprehensive reviews that summarise published findings, and also case studies that propose novel concepts and suggest important research directions.

Dr. Hanatsu Nagano
Collection Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.